Réponse à la correspondance de J-M. Pibourdin concernant l’article « Efficacité thérapeutique des chondroïtines sulfates dans l’arthrose. Méta-analyse différenciée du chondrosulf. Mise au point sur la structure, la sulfatation et le mode d’action »
暂无分享，去创建一个
[1] É. Pertuiset. Efficacité thérapeutique des chondroïtines sulfates dans l’arthrose Méta-analyse différenciée du Chondrosulf® Mise au point sur la structure, la sulfatation et le mode d’action , 2002 .
[2] B. Mazières,et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. , 2001, The Journal of rheumatology.
[3] D. Felson,et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.
[4] B. Leeb,et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. , 2000, The Journal of rheumatology.
[5] J. Dehais,et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. , 1998, Osteoarthritis and cartilage.
[6] E. Thonar,et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. , 1998, Osteoarthritis and cartilage.
[7] L. Bucsi,et al. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. , 1998, Osteoarthritis and cartilage.
[8] G. Saponati,et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. , 1996, The Journal of rheumatology.